HOXA-AS2 and cancer: In this study, we ascertained that the expression of HOXA-AS2 was upregulated in GC tissues, while significantly downregulated or revealed no expressional difference in other common types of cancer tissues, suggesting that HOXA-AS2 may be an independent clinical marker in GC prognosis and therapy.